Evidence map›Paper›PMID 24462114›Full record

ArticleMolecular cell2014

Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer.

Ioannis Sanidas, Christos Polytarchou, Maria Hatziapostolou, Scott A Ezell, Filippos Kottakis, Lan Hu, Ailan Guo, Jianxin Xie, Michael J Comb, Dimitrios Iliopoulos and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 120 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The insulin signalling network.Nature metabolism · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. AKT kinases as therapeutic targets.Journal of experimental & clinical cancer research : CR · 2024
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Ioannis SanidasMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Christos PolytarchouMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111, USA; Division of Digestive Diseases, Center for Systems Biomedicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Maria HatziapostolouMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111, USA; Division of Digestive Diseases, Center for Systems Biomedicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Scott A EzellMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Filippos KottakisMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Lan HuDepartment of Biostatistics and Computational Biology, Center for Cancer Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Ailan GuoCell Signaling Technology, Danvers, MA 01923, USA.
Jianxin XieCell Signaling Technology, Danvers, MA 01923, USA.
Michael J CombCell Signaling Technology, Danvers, MA 01923, USA.
Dimitrios IliopoulosDivision of Digestive Diseases, Center for Systems Biomedicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Philip N TsichlisMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111, USA. Electronic address: ptsichlis@tuftsmedicalcenter.org.
Tufts Medical Center · USCell Signaling Technology (United States) · USMolecular Oncology (United States) · USCenter for Systems Biology · USDana-Farber Cancer Institute · US

Funding

Akt in T cell development and functionR01CA057436 · NCI · TUFTS MEDICAL CENTER · PI TSICHLIS, PHILIP N. · 1994 to 2011
$3.2M
NCI NIH HHS R01 CA057436NCI NIH HHS R01CA57436
6 · The paper itself

Abstract

The three Akt isoforms are functionally distinct. Here we show that their phosphoproteomes also differ, suggesting that their functional differences are due to differences in target specificity. One of the top cellular functions differentially regulated by Akt isoforms is RNA processing. IWS1, an RNA processing regulator, is phosphorylated by Akt3 and Akt1 at Ser720/Thr721. The latter is required for the recruitment of SETD2 to the RNA Pol II complex. SETD2 trimethylates histone H3 at K36 during transcription, creating a docking site for MRG15 and PTB. H3K36me3-bound MRG15 and PTB regulate FGFR-2 splicing, which controls tumor growth and invasiveness downstream of IWS1 phosphorylation. Twenty-one of the twenty-four non-small-cell-lung carcinomas we analyzed express IWS1. More importantly, the stoichiometry of IWS1 phosphorylation in these tumors correlates with the FGFR-2 splicing pattern and with Akt phosphorylation and Akt3 expression. These data identify an Akt isoform-dependent regulatory mechanism for RNA processing and demonstrate its role in lung cancer.

Indexed as

Alternative SplicingGene Expression Regulation, NeoplasticAmino Acid SequenceAnimalsGene Expression RegulationHeLa CellsHistone-Lysine N-MethyltransferaseHistonesHumansLung NeoplasmsMiceMice, NudeMolecular Sequence DataNeoplasm TransplantationPhosphoproteinsPhosphorylationAKT1 protein, humanAkt1 protein, mouseAKT3 protein, humanAkt3 protein, mouseFGFR2 protein, humanFgfr2 protein, mouseHistone-Lysine N-MethyltransferaseHistonesIws1 protein, humanIWS1 protein, mousePhosphoproteinsProtein IsoformsProteinsProto-Oncogene Proteins c-aktReceptor, Fibroblast Growth Factor, Type 2RNARNA-Binding ProteinsSETD2 protein, humanSETD2 protein, mouseTranscription Factors

Identifiers

PMID24462114
PMCPMC3947584
OpenAlexW1984951395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.